Yini i-Retifanlimab: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Retifanlimab iyindlela entsha yokwelapha umdlavuza eyingxenye yohlu lwemithi ebizwa ngokuthi imithi yokwelapha ngomzimba. Isebenza ngokusiza amasosha akho omzimba ukuthi aqaphele futhi alwe namaseli omdlavuza ngempumelelo. Le mithi inikezwa ngomjovo we-IV esikhungweni sokwelapha umdlavuza, futhi yenzelwe ngqo ukwelapha izinhlobo ezithile zomdlavuza oqhubekayo ongazange uphendule kahle kwezinye izindlela zokwelapha.

Uma wena noma othile omkhathalelayo enikezwe i-retifanlimab, cishe unemibuzo eminingi mayelana nokuthi isebenza kanjani nokuthi yini ongayilindela. Ake sihambe kukho konke okudingeka ukwazi ngale ndlela yokwelapha ngendlela ezizwakala ilawuleka futhi icacile.

Yini i-Retifanlimab?

I-Retifanlimab uhlobo lomuthi wokwelapha ngomzimba obizwa ngokuthi i-PD-1 inhibitor. Cabanga nge-PD-1 njenge "bheki" emasosheni akho omzimba amanye amaseli omdlavuza awasebenzisela ukucasha ezivikelweni zomzimba wakho zemvelo. I-Retifanlimab isusa leli bheki, ivumela amasosha akho omzimba ukuthi athole kangcono futhi ahlaselwe amaseli omdlavuza.

Le mithi yilokho odokotela abakubiza ngokuthi i-monoclonal antibody, okusho ukuthi iyiphrotheni eyenziwe e-lab eyenzelwe ukugxila ezingxenyeni ezithile zamaseli omdlavuza. Ngokungafani ne-chemotherapy ethinta amaseli amaningi emzimbeni wakho, i-retifanlimab iqondiswe kakhulu endleleni yayo.

Lo muthi uza njengoketshezi okumele lunikezwe ngomjovo we-IV. Awukwazi ukuthatha le mithi njengepilisi noma umjovo ekhaya ngoba idinga ukulungiswa futhi iqashwe ngokucophelela ochwepheshe bezempilo.

Isetshenziselwani i-Retifanlimab?

I-Retifanlimab isetshenziswa ikakhulukazi ukwelapha i-Merkel cell carcinoma ethuthukile, uhlobo olungavamile nolunolaka lomdlavuza wesikhumba. Lo mdlavuza uvame ukuvela njengamabhampa aqinile, angenabuhlungu ezindaweni zesikhumba ezivezwe yilanga futhi angasakazeka ngokushesha kwezinye izingxenye zomzimba.

Udktela wakho angase ancome i-retifanlimab uma i-Merkel cell carcinoma yakho isisabalale kwezinye izindawo zomzimba wakho noma uma ibuye ngemva kokwelashwa kwangaphambilini. Ngokuvamile kucatshangelwa uma ukuhlinzwa kungenzeki noma lapho okunye ukwelashwa kungasebenzi.

Njengamanje, lo muthi uvunyelwe ngokuqondile kubantu abadala abanalo hlobo oluthile lomdlavuza. Ucwaningo luqhubeka ukuze kubonakale ukuthi lungasiza yini ngezinye izinhlobo zomdlavuza esikhathini esizayo, kodwa okwamanje ukusetshenziswa kwawo kugxilwe kakhulu.

Isebenza Kanjani I-Retifanlimab?

I-Retifanlimab isebenza ngokuvimba iphrotheni ebizwa nge-PD-1 ehlala ebusweni bamaseli akho omzimba. Uma i-PD-1 ivaliwe, amasosha akho omzimba aba matasa futhi akwazi kangcono ukuqaphela amaseli omdlavuza njengabahlaseli bangaphandle okudingeka baqedwe.

Lokhu kuthathwa njengokwelashwa komdlavuza okuqinile ngokulinganisela, kodwa kusebenza ngendlela ehlukile kunamakhemikhali endabuko. Esikhundleni sokubulala ngokuqondile amaseli omdlavuza, inika amandla amasosha akho omzimba ukuthi enze ukulwa. Le ndlela ingasebenza kahle kakhulu, kodwa futhi kusho ukuthi umuthi usebenza kancane kunezinye izindlela zokwelapha umdlavuza.

Imiphumela ye-retifanlimab ingaqhubeka ngisho nangemva kokuyeka ukuthola umuthi. Amasosha akho omzimba angase ahlale "eqeqeshwe" ukuqaphela nokulwa namaseli omdlavuza izinyanga noma iminyaka ngemva kokuphela kokwelashwa.

Kufanele Ngiyithathe Kanjani I-Retifanlimab?

I-Retifanlimab ihlale inikezwa njenge-IV infusion esibhedlela noma esikhungweni sokwelashwa komdlavuza. Ngeke nanini uthathe lo muthi ekhaya ngoba kudinga ukulungiswa nokuqapha ngokucophelela ochwepheshe bezempilo abaqeqeshiwe.

Ukufakwa ngomjovo ngokuvamile kuthatha imizuzu engaba ngu-30 kuya ehora elilodwa. Ngaphambi kokwelashwa kwakho, ungadla ngokujwayelekile futhi akudingeki ukuthi ugweme noma yikuphi ukudla okuthile. Abanye abantu bakuthola kuwusizo ukuba nokudla okulula ngaphambi kokuza ukuze bavimbele ukuzizwa bebuthakathaka ngesikhathi sokufakwa ngomjovo.

Uzoqokelwa esihlalweni esinethezekile ngesikhathi sokwelashwa, futhi abantu abaningi baletha izincwadi, amathebhulethi, noma eminye imisebenzi ethule yokudlulisa isikhathi. Abasebenzi abahlengikazi bazokuqapha eduze ngesikhathi nangemva kokufakwa komuthi ukuze babheke noma yiziphi izindlela zokuphendula ngokushesha.

Qiniseka ukuthi uphuza amanzi amaningi ngaphambi nangemva kokwelashwa kwakho. Ukuhlala unamanzi kahle kungasiza umzimba wakho ukuthi usebenze imithi ngempumelelo futhi kunganciphisa eminye imiphumela engemihle.

Kufanele Ngithathe Isikhathi Esingakanani I-Retifanlimab?

Ubude bokwelashwa nge-retifanlimab buhlukahluka kakhulu kumuntu nomuntu. Abantu abaningi bathola ukufakwa komuthi njalo emavikini amathathu kuya kwamane, kodwa isimiso sakho esiqondile sincike ekutheni umdlavuza uphendula kahle kangakanani nokuthi umzimba wakho uyayibekezelela kanjani imithi.

Abanye abantu bangase bathole ukwelashwa izinyanga eziningana, kanti abanye bangase baqhubeke unyaka noma ngaphezulu. Udokotela wakho we-oncologist uzosebenzisa izithombe ezivamile nokuhlolwa kwegazi ukuze aqaphe ukuthi ukwelashwa kusebenza kahle kangakanani nokuthi kuphephile yini ukuqhubeka.

Izindaba ezinhle ukuthi lokhu kwelashwa akulandeli uhlelo oluqinile njengamanye ama-chemotherapy regimens. Udokotela wakho uzosebenza nawe ukuze athole ubude obufanele ngokuya ngempendulo yakho yomuntu ngamunye nempilo yonke.

Ukwelashwa kuvame ukuqhubeka uma nje kusiza ukulawula umdlavuza futhi imiphumela engemihle ihlala ilawuleka. Uma umdlavuza uqala ukukhula futhi noma imiphumela engemihle iba yimbi kakhulu, udokotela wakho uzoxoxa ezinye izinketho nawe.

Yiziphi Imiphumela Engemihle Ye-Retifanlimab?

Njengazo zonke izindlela zokwelapha umdlavuza, i-retifanlimab ingabangela imiphumela engemihle, nakuba abantu abaningi beyibekezelela kangcono kune-chemotherapy yendabuko. Imiphumela engemihle evame kakhulu ivamise ukulawuleka futhi ithambekele ekuthuthukiseni ngokuhamba kwesikhathi njengoba umzimba wakho uzivumela emithini.

Imiphumela engemihle ongase uyithole ingena ezigabeni eziningana, futhi kubalulekile ukuqonda ukuthi yini ejwayelekile nokuthi yini edinga ukunakekelwa kwezokwelapha ngokushesha.

Imiphumela evamile eceleni abantu abaningi abahlangabezana nayo ihlanganisa:

• Ukukhathala okungase kuzizwe kuhluke ekukhathaleni okuvamile
• Ukuqubuka kwesikhumba noma ukuluma okungavela noma yikuphi emzimbeni wakho
• Ukuphuma isifo sohudo noma izinguquko ekuhambeni kwamathumbu
• Isicanucanu noma ukuncipha kwesifiso sokudla
• Ukulimala kwemisipha noma amalunga
• Ukukhwehlela noma izinguquko ezincane zokuphefumula

Le miphumela evamile eceleni ivame ukuba mncane kuya phakathi nendawo futhi ivamise ukuthuthuka njengoba umzimba wakho ujwayela ukwelashwa. Ithimba lakho lezempilo linganikeza imithi namasu okusiza ukuphatha lezi zimpawu.

Imiphumela eceleni engathi sína edinga ukunakekelwa kwezokwelapha ngokushesha ihlanganisa:

• Isifo sohudo esibi esingathuthuki ngemithi
• Ukuphefumula kanzima noma ukukhwehlela okuqhubekayo
• Ukuphendula kwesikhumba okukhulu noma ukuqubuka okusabalale kakhulu
• Ukukhathala okungavamile noma ubuthakathaka obuqhubeka bubi ngokuhamba kwesikhathi
• Ushintsho embonweni noma ikhanda elibuhlungu elibuhlungu
• Izimpawu zezinkinga zesibindi njengokuphuzi kwesikhumba noma amehlo

Le miphumela eceleni engathi sína yenzeka ngoba i-retifanlimab ngezinye izikhathi ingabangela ukuthi amasosha akho omzimba ahlaselwe izitho ezinempilo emzimbeni wakho. Ngenkathi lokhu kungavamile, yingakho ukuqapha njalo kubaluleke kakhulu ngesikhathi sokwelashwa.

Imiphumela eceleni engavamile kodwa engathi sína ehlobene nokuzivikela komzimba ingathinta:

• Amaphaphu akho, okubangela ukuvuvukala okuholela ezinkingeni zokuphefumula
• Isibindi sakho, okungenzeka sibangele ama-enzyme esibindi aphakeme noma i-jaundice
• Uhlelo lwakho lokugaya ukudla, oluholela ku-colitis engathi sína noma ukuvuvukala kwamathumbu
• Uhlelo lwakho lwe-endocrine, oluthinta amahomoni afana ne-thyroid noma umsebenzi we-adrenal
• Uhlelo lwakho lwezinzwa, nakuba lokhu kungavamile

Ngenkathi le miphumela eceleni engavamile izwakala ikhathaza, ithimba lakho lezokwelapha liqeqeshwe ukubheka izimpawu zakuqala futhi lingazelapha ngempumelelo uma zitholwe kusenesikhathi. Abantu abaningi abahlangabezana nale miphumela eceleni bangaqhubeka nokwelashwa ngokuphathwa okufanele.

Ubani Ongafanele Athole I-Retifanlimab?

I-Retifanlimab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi iyona yini ekufanele esimweni sakho esithile. Abantu abanezimo ezithile zezokwelapha noma izimo kungenzeka badinge ukugwema lokhu kwelashwa noma bakusebenzise ngokuqapha okwengeziwe.

Akufanele uthole i-retifanlimab uma uke waba nokusabela okukhulu komzimba kulo muthi noma imithi efanayo ye-immunotherapy esikhathini esidlule. Izimpawu zokusabela okukhulu komzimba zihlanganisa ubunzima bokuphefumula, ukuvuvukala okukhulu, noma ukuqubuka okubanzi okubonakala ngokushesha ngemva kokwelashwa.

Udokotela wakho uzodinga ukucabangela ngokucophelela i-retifanlimab uma une:

• Izifo ze-autoimmune ezisebenzayo njenge-rheumatoid arthritis noma i-lupus
• Umlando wokufakelwa kwezitho ngoba uthatha imithi ecindezela amasosha omzimba
• Isifo esibi samaphaphu noma izinkinga zokuphefumula
• Izifo ezisebenzayo ezilwa amasosha akho omzimba
• Isifo sesibindi noma ama-enzyme esibindi aphakanyiswe kakhulu
• Isifo samathumbu esivuvukalayo njengesifo sikaCrohn noma i-ulcerative colitis

Ukuba nenye yalezi zimo akusho ngokuzenzakalelayo ukuthi awukwazi ukuthola i-retifanlimab, kodwa kusho ukuthi udokotela wakho uzodinga ukukuqapha eduze futhi mhlawumbe alungise uhlelo lwakho lokwelashwa.

Izinto ezikhethekile okufanele zicatshangelwe uma:

• Ukhulelwe noma ungase ukhulelwe ngesikhathi sokwelashwa
• Uncelisa noma uhlela ukuncelisa
• Uthatha imithi ecindezela amasosha akho omzimba
• Uthola imithi yokugoma esanda kutholakala

Udokotela wakho we-oncologist uzosebenza nawe ukuze alinganise izinzuzo ezingaba khona nezingozi, ecabangela impilo yakho yonke nobukhulu bomdlavuza wakho. Ngezinye izikhathi izinzuzo zokwelashwa zidlula izingozi, ngisho nalapho izimo ezithile zikhona.

Amagama Omkhiqizo we-Retifanlimab

I-Retifanlimab ithengiswa ngaphansi kwegama lomkhiqizo elithi Zynyz e-United States. Leli yigama ozolibona emaphepheni akho okwelashwa kanye nemibhalo yomshuwalense.

Igama eliphelele lobuchwepheshe lithi retifanlimab-dlwr, lapho ingxenye ethi "dlwr" isiza ukuyihlukanisa neminye imithi efanayo. Ungase ulibone leli gama elide emibhalweni ethile yezokwelapha noma ezifundweni zocwaningo.

Ngokungafani neminye imithi enamagama amaningi omkhiqizo, i-retifanlimab njengamanje inegama elilodwa lomkhiqizo emakethe yase-U.S. Lokhu kungenza kube lula ukulandela ukwelashwa kwakho futhi uxhumane nethimba lakho lezempilo mayelana nomuthi wakho.

Ezinye izindlela zokwelapha i-Retifanlimab

Uma i-retifanlimab ingakulungele noma iyeka ukusebenza ngempumelelo, ezinye izinketho zokwelapha zingase zitholakale. Enye indlela engcono kakhulu incike ohlotsheni lwakho oluthile lomdlavuza, impilo yakho yonke, nokuthi usabele kanjani ekwelashweni kwangaphambilini.

Eminye imithi ye-immunotherapy ebizwa ngokuthi ama-PD-1 inhibitors ihlanganisa i-pembrolizumab (Keytruda) kanye ne-nivolumab (Opdivo). Lezi zisebenza ngendlela efanayo ne-retifanlimab kodwa zingase zibe nemiphumela emincane ehlukile noma amashejuli okulinganisa.

Ngokuqondile i-Merkel cell carcinoma, i-avelumab (Bavencio) ingenye inketho ye-immunotherapy eqondise iphrotheni ehlukile kancane ebizwa ngokuthi i-PD-L1. Abanye abantu abangayisabeli kahle ohlotsheni olulodwa lwe-immunotherapy bangase babe nemiphumela engcono ngolunye.

Ukwelashwa kwendabuko okufana ne-chemotherapy, i-radiation therapy, noma ukuhlinzwa kungase kucatshangelwe kuye ngesimo sakho. Udokotela wakho we-oncologist uzoxoxa nazo zonke izinketho ezitholakalayo nawe uma i-retifanlimab ingafaneleki.

Ingabe i-Retifanlimab ingcono kunezinye izinto ezivimbela i-PD-1?

I-Retifanlimab intsha uma iqhathaniswa nezinye izinto ezivimbela i-PD-1 njenge-pembrolizumab kanye ne-nivolumab, ngakho-ke akukho cwaningo oluningi oluqhathanisa ngokuqondile. Umuthi ngamunye unamandla awo futhi ungasebenza kangcono kubantu abahlukene.

Okuthi i-retifanlimab ihlukile wukuthi yacwaningwa ngokukhethekile futhi yagunyazwa nge-Merkel cell carcinoma, kuyilapho ezinye izivimbeli ze-PD-1 ekuqaleni zazenzelwe ezinye izinhlobo zomdlavuza. Lokhu kuthuthukiswa okugxilwe kukho kusho ukuthi indlela yokulinganisa nokwelapha iye yathuthukiswa ngale ndlela ethile yomdlavuza.

Ukuvela kwemiphumela emibi ye-retifanlimab kubonakala kufana neminye imithi ekulesi sigaba, kodwa abanye abantu bangase bakwazi ukubekezelela eyodwa kangcono kunenye. Udokotela wakho uzocabangela umlando wakho wezokwelapha kanye nezici zomdlavuza wakho lapho ekhetha inketho engcono kakhulu.

Esikhundleni sokucabanga ukuthi iyiphi imithi “engcono,” kusiza kakhulu ukucabanga ukuthi iyiphi efaneleka kakhulu esimweni sakho ngasinye. Udokotela wakho we-oncologist uzokusiza ukuthi uqonde ukuthi kungani i-retifanlimab ikhethelwe uhlelo lwakho lokwelapha.

Imibuzo Evame Ukubuzwa Mayelana ne-Retifanlimab

Ingabe i-Retifanlimab iphephile kubantu abanezifo ze-Autoimmune?

I-Retifanlimab idinga ukucatshangelwa ngokucophelela uma unesifo se-autoimmune. Njengoba le mithi isebenzisa amasosha akho omzimba, ingase iqhubekisele phambili izimo ze-autoimmune ezifana ne-rheumatoid arthritis, i-lupus, noma i-multiple sclerosis.

Noma kunjalo, ukuba nesifo se-autoimmune akukukhiphi ngokuzenzakalelayo ekutholeni i-retifanlimab. Udokotela wakho we-oncologist uzosebenza ngokubambisana nodokotela bakho abanye ukuze alinganise izinzuzo zokwelashwa komdlavuza ngokumelene nengozi yokwenza isimo sakho se-autoimmune sikhule.

Uma uthola i-retifanlimab ngesifo se-autoimmune, uzodinga ukuqapha okwengeziwe futhi mhlawumbe ukulungiswa kweminye imithi yakho. Abanye abantu bangakwazi ukuphathwa ngempumelelo ngokuphathwa ngokucophelela kwesimo sabo se-autoimmune.

Kufanele ngenzeni uma ngithola i-Retifanlimab eningi ngengozi?

Ukweqisa umthamo we-retifanlimab akunakwenzeka ngoba imithi ihlale ilungiswa futhi inikezwe ochwepheshe bezempilo abaqeqeshiwe endaweni enakekelwe yezokwelapha. Umthamo ubalwa ngokucophelela ngokusekelwe esisindweni sakho kanye nesimo sezempilo.

Uma ukhathazekile ngokuthi kungenzeka ukuthi uthole umthamo ongalungile, khuluma nethimba lakho lezempilo ngokushesha. Bangakwazi ukubukeza amarekhodi akho okwelashwa futhi bakuqaphele nganoma yiziphi izimpawu ezingavamile.

Izimpawu zokuthola i-retifanlimab eningi kakhulu cishe zizofana nemiphumela engemihle ejwayelekile kodwa kungenzeka ibe yimbi kakhulu. Ithimba lakho lezokwelapha liqeqeshwe ukubona nokwelapha lezi zimo uma zenzeka.

Kufanele ngenzeni uma ngiphuthelwa umthamo we-Retifanlimab?

Uma uphuthelwa ukufakwa kwe-retifanlimab okuhleliwe, xhumana nehhovisi likadokotela wakho we-oncologist ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Ungazami ukwenza umthamo ophuthelwe ngokushintsha uhlelo lwakho ngokwakho.

Ithimba lakho lezempilo lizokusiza ukuthi unqume isikhathi esingcono kakhulu sokufakwa kwakho okulandelayo ngokusekelwe ekutheni uphuthelwe nini umthamo nokuthi uzizwa kanjani. Ngezinye izikhathi ukubambezeleka okuncane akuthinti ngendlela enkulu ukusebenza kokwelashwa.

Zama ukuhlela kabusha phakathi nezinsuku ezimbalwa kuya evikini lesikhathi sakho sokuqokwa sokuqala uma kungenzeka. Udokotela wakho angase akufunele ukuhlolwa okusheshayo ngaphambi kokunikeza umthamo obambezelekile ukuze aqiniseke ukuthi usafaneleka kahle ukwelashwa.

Ngingayeka nini ukuthatha i-Retifanlimab?

Isinqumo sokuyeka i-retifanlimab sincike ekutheni isebenza kahle kangakanani nokuthi ukubekezelela kanjani ukwelashwa. Udokotela wakho we-oncologist uzosebenzisa ukuskena okujwayelekile nokuhlolwa kwegazi ukuze aqaphele inqubekela phambili yakho futhi anqume isikhathi esifanele sokuyeka.

Ungase uyeke i-retifanlimab uma umdlavuza wakho ubonisa izimpawu zokukhula naphezu kokwelashwa, uma uba nemiphumela engemihle engemihle kakhulu ukuthi ingalawulwa, noma uma uthola impendulo enhle futhi udokotela wakho ezwa ukuthi kuphephile ukuphumula.

Abanye abantu bangayeka ukwelashwa futhi bahlale bengenayo umdlavuza izinyanga noma iminyaka, kanti abanye bangase badinge ukuqhubeka nokwelashwa isikhathi eside. Isikhathi sinqunywa ngumuntu ngamunye futhi sincike ezintweni eziningi ezithinta isimo sakho.

Ungayeki ukuthatha i-retifanlimab ngokwakho ngaphandle kokuxoxa ngayo nodokotela wakho we-oncologist kuqala. Noma ngabe uzizwa kahle, ukuyeka ukwelashwa ngesikhathi esingafanele kungavumela umdlavuza ukuthi ubuye noma ukhule.

Ngingakwazi Ukuthola Imigomo Ngenkathi Ngithatha I-Retifanlimab?

Kufanele ugweme imigomo ebukhoma ngenkathi uthola i-retifanlimab ngoba amasosha akho omzimba ashintshiwe angase angakwazi ukuphatha ngendlela ephephile. Imigomo ebukhoma ihlanganisa izinto ezinjengomgomo womkhuhlane wokufutha ngamakhala, umgomo we-shingles, neminye imigomo yokuhamba.

Imigomo engasebenzi njengomgomo ovamile womkhuhlane ngokuvamile iphephile futhi ivame ukunconywa ngesikhathi sokwelashwa nge-retifanlimab. Amasosha akho omzimba angase angasabeli ngokuqinile emigomweni, kodwa angasanikeza ukuvikelwa okuthile.

Njalo hlola nodokotela wakho we-oncologist ngaphambi kokuthola noma yimuphi umgomo ngesikhathi sokwelashwa. Bangakuncoma ukuthi yimiphi imigomo ephephile futhi basize ukuxhumanisa isikhathi neshejuli yakho yokwelashwa.